The California Stem Cell Report

Home
sustainability
cirm future
CIRM's $3.9 Billion Priority …
A CIRM Primer -- A to Z
CIRM Sustainability
Leaderboard
About
Capricor Says CIRM-Backed Therapy is 'Well Postioned' to Move Forward to Clinical Use
Stock rises in trading Tuesday
 • 
David Jensen
Capricor, the FDA and Millions from the State of California
Stock price of the San Diego firm drops 31 percent on Friday
 • 
David Jensen
Waning Financial Enthusiasm for Gene Therapies: National Picture is Bleak, Says Barron's
California multibillion-dollar program scheduled to discuss its research portfolio next week
 • 
David Jensen
Most Popular
View all
California's Stem Cell/Gene Therapy Agency, a Man Named Marks and the Future
 • David Jensen
2
A CIRM Sibling is Gestating in the California Legislature
 • David Jensen
From Market Studies to 'Value' Messaging, California Stem Cell/Gene Therapy Agency Bets Big on Affordability Plan
 • David Jensen
From the Pacific Ocean to the City of Hope, a Tale of Destruction, Fire and Science
 • David Jensen
2
California Launches $429 Million in New Stem Cell/Gene Therapy Plans, Striving for Bigger Impact plus Speeding Commercialization
 • David Jensen
1,000 Strong: Rare Disease Advocates Pitch for Billions in Research from California Stem Cell Agency
 • David Jensen
Sarepta's Stock Sinks Sharply Following News of Second Death Involving Genetic Therapy
$3.2 million treatment, Duchenne disorder and 'regulatory flexibility' involved
 • 
David Jensen
Second Death in Gene Therapy Trial for a Rare Muscle Degenerative Disorder
'Regulatory flexibility' issues surrounding the case could affect development of other gene therapies, including those financed by California taxpayers.
 • 
David Jensen
Who are the Big Winners of California's Billions for Stem Cell and Gene Therapy Research?
The money flows from San Diego to Sacramento.
 • 
David Jensen
California's Stem Cell/Gene Therapy Budget to Hit All-Time High of More than $500 Million
Spending plan boosted to help deal with Trump's research machinations
 • 
David Jensen
Death in Clinical Trial Supported With $5.8 Million From California Stem Cell and Gene Therapy Agency
Rocket Pharma says it will seek to move forward with the treatment; company's stock plummets
 • 
David Jensen
Financial Conundrum: Half-a-Billion Dollar Spending Gap in California Stem Cell/Gene Therapy Research
CIRM says it is not slow walking awards
 • 
David Jensen
California Effort to Create a State Version of the NIH Stalls; Was Response to Trump Research Turmoil
State budget woes suspend the legislation, approval unlikely this year
 • 
David Jensen
The California Stem Cell Report
An inside and independent look at the Golden State's $12 billion stem cell research program, how it works, who wins and who loses, its conflicts of interest and its changing priorities.
Recommendations
The Good Science Project
The Good Science Project
Stuart Buck
GoozNews
GoozNews
Merrill Goozner
User's avatar
Cell & Gene weekly
Marco Sabatini

The California Stem Cell Report

AboutArchiveRecommendationsSitemap
© 2025 David Jensen
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture